How are these new GLP-1 medications different from older treatments for obesity?

New GLP-1 and GLP-1 combination medications like semaglutide (Wegovy®) and tirzepatide (Mounjaro™) show significantly higher and more durable weight loss results compared to earlier medications. They also improve broader metabolic health markers, reducing the risk of chronic conditions that drive long-term healthcare costs.